Anavex Life Sciences Corp (AVXL)

10.87 -0.31 (-2.77%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Anavex Life Sciences Cash and Short Term Investments (Quarterly): 132.19M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Avid Bioservices Inc 33.42M
Alaunos Therapeutics Inc 1.683M
SELLAS Life Sciences Group Inc 21.03M
Galectin Therapeutics Inc 27.06M
Oragenics Inc 3.144M